Mg0017 50111 — Seattle, Washington

Mg0017 50111 is a clinical research site located in Seattle, Washington, United States 98195-0001.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mg0017 50111 has participated in 1 clinical trials.

Therapeutic areas: Generalized Myasthenia Gravis.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mg0017 50111?

Mg0017 50111 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mg0017 50111 conducted?

Mg0017 50111 has 1 clinical trials on record. Their work covers Generalized Myasthenia Gravis.

Is Mg0017 50111 accredited by Crixeo Health?

Mg0017 50111 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mg0017 50111?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.